📊 CNVS Key Takeaways
Investment Thesis
Cineverse Corp exhibits severe operational distress with persistent operating losses (-24.6% margin), significantly negative free cash flow (-$24.4M), and deteriorating liquidity (0.95x current ratio). The company is burning cash at an unsustainable rate while generating minimal revenue growth, indicating fundamental business model challenges in the legacy video rental sector.
CNVS Strengths
- Conservative debt levels with Debt/Equity of only 0.08x, providing borrowing capacity
- Positive net income improvement trend with net loss narrowing by 16% YoY and EPS improving 109% YoY
- Modest equity base of $38.6M remains positive, reducing immediate insolvency risk
CNVS Risks
- Severe cash burn with operating cash flow of -$23.3M and free cash flow of -$24.4M consuming equity rapidly
- Critical liquidity position with current ratio of 0.95x indicating inability to cover near-term obligations
- Stagnant revenue with 0% YoY growth in declining industry sector, suggesting structural business model obsolescence
- Negative interest coverage of -2.2x indicates inability to service debt from operations
- Unsustainable free cash flow margin of -61.3% demonstrates losses exceed revenue
Key Metrics to Watch
- Operating cash flow trajectory and path to positive FCF
- Cash balance depletion rate relative to monthly burn rate
- Revenue stabilization and growth initiatives in streaming/digital transition
- Current ratio and working capital adequacy for operational continuity
- Success of restructuring or strategic alternatives given 8 insider Form 4 filings
CNVS Financial Metrics
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
CNVS Profitability Ratios
CNVS vs Default Sector
How Cineverse Corp. compares to Default sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
CNVS Balance Sheet & Liquidity
CNVS 5-Year Financial Trend
5-Year Trend Summary: Cineverse Corp.'s revenue has grown significantly by 5,484% over the 5-year period, indicating strong business expansion. The most recent EPS of $-1.78 indicates the company is currently unprofitable.
CNVS Growth Metrics (YoY)
CNVS Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2026 | $16.3M | -$875.0K | $-0.05 |
| Q2 2026 | $12.4M | -$1.2M | $-0.09 |
| Q1 2026 | $9.1M | -$3.1M | $-0.20 |
| Q3 2025 | $13.3M | -$317.0K | $0.12 |
| Q2 2025 | $12.7M | -$317.0K | $-0.04 |
| Q1 2025 | $9.1M | -$3.1M | $-0.20 |
| Q3 2024 | $13.3M | -$317.0K | $-0.22 |
| Q2 2024 | $13.0M | -$317.0K | $-0.04 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
CNVS Capital Allocation
CNVS SEC Filings
Access official SEC EDGAR filings for Cineverse Corp. (CIK: 0001173204)
📋 Recent SEC Filings
❓ Frequently Asked Questions about CNVS
What is the AI rating for CNVS?
Cineverse Corp. (CNVS) has an AI rating of STRONG SELL with 92% confidence, based on fundamental analysis of SEC EDGAR filings.
What are CNVS's key strengths?
Conservative debt levels with Debt/Equity of only 0.08x, providing borrowing capacity. Positive net income improvement trend with net loss narrowing by 16% YoY and EPS improving 109% YoY.
What are the risks of investing in CNVS?
Severe cash burn with operating cash flow of -$23.3M and free cash flow of -$24.4M consuming equity rapidly. Critical liquidity position with current ratio of 0.95x indicating inability to cover near-term obligations.
What is CNVS's revenue and growth?
Cineverse Corp. reported revenue of $39.8M.
Does CNVS pay dividends?
Cineverse Corp. does not currently pay dividends.
Where can I find CNVS SEC filings?
Official SEC filings for Cineverse Corp. (CIK: 0001173204) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is CNVS's EPS?
Cineverse Corp. has a diluted EPS of $-0.57.
How is the AI analysis conducted?
Our AI (Claude) analyzes publicly available SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports to evaluate financial health, profitability ratios, balance sheet strength, and growth metrics.